Schisandrin a

1. Schisandrin a decreases inflammation in human cells.

   “alleviated IL-1β-induced chondrocyte injury. It restored anabolic metabolism, suppressed catabolic activity, and reduced inflammatory and fibrotic responses.”

   Cellsin IL-1β-stimulated CHON-001 cells

   Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway

   Bioscience, biotechnology, and biochemistry·29 Jan 2026

More on Inflammation

1. Schisandrin a inhibits PI3K–AKT signalling in human cells.

   “Functional assays confirmed that Sch-A suppressed senescence-associated secretory phenotype factors, senescence markers, SA-β-galactosidase activity, and PI3K/Akt activation”

   Cellsin IL-1β-stimulated CHON-001 cells

   Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway

   Bioscience, biotechnology, and biochemistry·29 Jan 2026

More on PI3K–AKT signalling

1. Schisandrin a decreases senescence-associated beta-galactosidase in human cells.

   “Functional assays confirmed that Sch-A suppressed senescence-associated secretory phenotype factors, senescence markers, SA-β-galactosidase activity”

   Cellsin IL-1β-stimulated CHON-001 cells

   Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway

   Bioscience, biotechnology, and biochemistry·29 Jan 2026

More on Senescence-associated beta-galactosidase

1. Schisandrin a decreases cellular senescence in human cells.

   “Sch-A mitigates chondrocyte senescence and metabolic dysregulation by modulating PI3K/Akt signaling”

   Cellsin IL-1β-stimulated CHON-001 cells

   Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway

   Bioscience, biotechnology, and biochemistry·29 Jan 2026

More on Cellular senescence